SK bioscience Co.,Ltd. (302440.KS) KSC

47,000.00

+200(+0.43%)

Updated at September 29 09:35AM

Currency In KRW

Valuation

Market Cap3.89T
Enterprise Value3.97T
P/E Ratio-69.68
PEG Ratio6.98
Price/Sales Ratio6.86
Price/Book Ratio2.05
Enterprise/Revenue7.15
Enterprise/EBITDA-1,118.09

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-0.1
Operating Margin-0.27

Management Effectiveness

Return On Assets-0.02
Return On Equity-0.03

Income Statement

Revenue267.55B
Revenue/Share6,818.1
Gross Profit30.98B
EBITDA-36.2B
Net Income-53.88B
Diluted EPS-701.32

Balance Sheet

Total Cash1.1T
Total Cash/Share13,979.63
Total Debt402.11B
Total Debt/Equity0.22
Current Ratio4.48
Book Value Per Share25,807.11

Price History

52-Week Change-15.52
52-Week High58,700
52-Week Low35,800
Moving Average 50 Days47,765
Moving Average 200 Days46,024.5

Statistics

Average Volume126,940
Shares Outstanding78.37M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A